An Introduction to Geriatric Oncology
Adults aged 65 years or more account for approximately half of all cancer cases. Geriatric care brings with it additional challenges for oncologists, such as treatment tolerance and managing comorbidities which can play a large role in the availability of treatment options.
Expert video highlights, insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape.
Geriatric Oncology Content
Nicolaus Kröger, ASH 2018 – Treatment of Myelodysplastic Syndrome in Elderly Patients
Professor Nicolaus Kröger spoke to us at ASH 2018 about the major unmet needs in the treatment of myelodysplastic syndrome in elderly patients, and his phase III study comparing 5-azacytidine induction followed by allogeneic stem cell transplantation versus continuous 5-azacytidine according to donor availability in elderly patients with myelodysplastic syndrome. Questions: 1. What are the […]
Supporting Older People with Cancer – Merging Geriatric and Oncological Knowledge
European Oncology & Haematology, 2016;12(1):23–4 DOI: https://doi.org/10.17925/EOH.2016.12.01.23
It is well known that there is a demographic transition all over the world. The most important explanation to this is the change from previously large groups of children in a family to now commonly only one or two children in most countries. This decrease in birth giving together with improved longevity means that most […]
Cancer screening complications in the elderly
“Population-based screening is causing more harm than good,” Dr Kataja (Kuopio University Hospital, Kuopio, Finland) says to ecancertv at SIOG 2014. He discusses the complications of cancer screening in the elderly, particularly the risks and benefits of prostate and breast cancer screening in geriatric patients.
Breast Cancer Screening in Older Women— Current Evidence and Future Perspectives
Oncology & Hematology Review, 2015;11(1):34–5 DOI: https://doi.org/10.17925/OHR.2015.11.01.34
Breast cancer remains one of the largest contributors to cancer mortality in women in developed countries.1,2 As populations of developed countries are aging, the number of older women who have breast cancer will markedly increase in the upcoming decades. It has been shown that breast cancer prognosis deteriorates with age, even though mortality for other […]
A Systematic Review of Factors Influencing Older Adults’ Hypothetical Treatment Decisions
Oncology & Hematology Review, 2015;11(1):19–33 DOI: https://doi.org/10.17925/OHR.2015.11.01.19
Cancer is a significant health problem in older persons.1 It is estimated that 42 % of all incident cases and over 60 % of mortality due to cancer occur in persons aged 70 and over.1,2 With the aging of the population there will be a considerable increase in the number of older adults diagnosed with […]
Advance Care Planning in Oncology
Cicely Saunders Institute Seminar by Dr Andrew Epstein, MD, Assistant Attending, GI Medical Oncology Service, Memorial Sloan Kettering Cancer Center (MSKCC), and Instructor of Medicine, Weill Medical College of Cornell University, New York
Capecitabine for elderly early-stage breast cancer
In elderly breast cancer patients with moderate- to high-risk early-stage disease for whom standard chemotherapy is too toxic, the chemotherapy capecitabine, which causes fewer side effects than the standard chemotherapy agents, did not improve outcomes when tested as monotherapy.
What is ‘frailty’ in elderly cancer patients?
Frailty is a very debated concept in the treatment of elderly cancer patients, Dr Rainfray (Bordeaux Hospital University Center, Bordeaux, France) tells ecancertv at SIOG 2014. She discusses a definition of geriatric frailty, metrics for determining whether a patient is frail, and its implications for cancer treatment.
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!